Crispr

Early CRISPR Trial Shows Promise for Sickle Cell Disease

Researchers have reported encouraging early results from a Phase 1/2 clinical trial of a new CRISPR-based gene-editing therapy for sickle cell disease, offering fresh hope for patients living with…